+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bristol-Myers Squibb - logo

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

From
Antimicrobial Therapeutics Market 2024-2028 - Product Thumbnail Image

Antimicrobial Therapeutics Market 2024-2028

  • Report
  • June 2024
  • 175 Pages
  • Global
From
Adult Malignant Glioma Therapeutics Global Market Report 2024 - Product Thumbnail Image

Adult Malignant Glioma Therapeutics Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
Brain Tumor Drugs Global Market Report 2024 - Product Thumbnail Image

Brain Tumor Drugs Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Small Cell Lung Cancer Therapeutics Global Market Report 2024 - Product Thumbnail Image

Small Cell Lung Cancer Therapeutics Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
Pediatric Neuroblastoma Treatment Global Market Report 2024 - Product Thumbnail Image

Pediatric Neuroblastoma Treatment Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Glioma Treatment Global Market Report 2024 - Product Thumbnail Image

Glioma Treatment Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Sickle Cell Disease Treatment - Global Strategic Business Report - Product Thumbnail Image

Sickle Cell Disease Treatment - Global Strategic Business Report

  • Report
  • November 2024
  • 182 Pages
  • Global
From
Hematological Malignancies - Global Strategic Business Report - Product Thumbnail Image

Hematological Malignancies - Global Strategic Business Report

  • Report
  • November 2024
  • 193 Pages
  • Global
From
From
From
Tislelizumab (BeiGene) Drug Overview 2019 - Product Thumbnail Image

Tislelizumab (BeiGene) Drug Overview 2019

  • Report
  • September 2019
  • 13 Pages
  • Global
Lung Cancer Drugs Global Market Report 2024 - Product Thumbnail Image

Lung Cancer Drugs Global Market Report 2024

  • Report
  • November 2023
  • 175 Pages
  • Global
From
From
Loading Indicator